The 6th International Congress on Cardiac Problems in Pregnancy (CPP 2020 )

April 2 – 5 , 2020

Porto, Portugal


We would like to enthusiastically invite you to attend “The 6th International Congress on Cardiac Problems in Pregnancy (CPP) 2020″ which will take place in Porto, Portugal on April 2 – 5, 2020. The goals of the congress is to advance the knowledge and expertise of health care professionals around the globe by exchange of information, development of collaborative research and adopt and update recent guidelines for the management of cardiovascular (CV) diseases during pregnancy and the post partum period.
The CPP2020 builds upon the previous four successful meetings in Valencia, Spain, Berlin, Germany, Venice, Italy and Las Vegas, United States and Bologna, Italy, which covered a wide range of topics, related to maternal and fetal cardiac conditions associated to pregnancy and were attended by more than 400 participants including many of the leaders in the field. The congress will include a large number of plenary sessions with state of the art reviews and will incorporate results of research both basic and clinical as well as clinical observations with a focus on practical management recommendations. In addition, the Congress will include updates of on-going registries, developing guidelines, case studies, clinical debates, and panel discussions.
The program was designed to provide a high level and clinically relevant update on the diagnosis, prognosis and management of women with a broad spectrum of pregnancy-related CV problems with the goal of improving the care of these patients.
Because the management of heart disease in pregnancy requires a multidisciplinary approach, the intended audience will include cardiologists, obstetricians, maternal-fetal medicine specialists, family medicine specialists, haematologists, paediatricians, paediatric cardiologists, geneticists, cardiac surgeons, Obstetrical and cardiac anaesthesiologists, nurses, clinical pharmacists and other health professionals with special interest in managing pregnant women with heart disease.